An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Open accessThe DOI matches its Crossref record; 324 of the 325 references it cites were found in a registry or an index.
Abstract
This document is an international evidence-based guideline on the diagnosis and management of idiopathic pulmonary fibrosis, and is a collaborative effort of the American Thoracic Society, the European Respiratory Society, the Japanese Respiratory Society, and the Latin American Thoracic Association. It represents the current state of knowledge regarding idiopathic pulmonary fibrosis (IPF), and contains sections on definition and epidemiology, risk factors, diagnosis, natural history, staging and prognosis, treatment, and monitoring disease course. For the diagnosis and treatment sections, pragmatic GRADE evidence-based methodology was applied in a question-based format. For each diagnosis and treatment question, the committee graded the quality of the evidence available (high, moderate, low, or very low), and made a recommendation (yes or no, strong or weak). Recommendations were based on majority vote. It is emphasized that clinicians must spend adequate time with patients to discuss patients' values and preferences and decide on the appropriate course of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, all patients originally gathered from hospital register using ICD-10 codes were meticulously re-assessed and re-classified using the year 2011 criteria, and the cases representing some other type of ILDs were excluded [14].”
From Comparison of disease progression subgroups in idiopathic pulmonary fibrosis (2019) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ILD still has a poor prognosis and the highest mortality rate during lung transplantation.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [48]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interstitial lung disease (ILD) remains an important indication for lung transplantation, and the number of patients with this disease is increasing.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [48]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Idiopathic pulmonary fibrosis (IPF), characterized histopathologically and/or radiologically with a usual interstitial pneumonia (UIP) pattern, is the most common adult form of interstitial pneumonia of unknown origin [1].”
From Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature (2014) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The median survival time for patients with IPF is 2 to 3 years from diagnosis and the 5-year survival rate ranges between 30% and 50% [1,5-7].”
From Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature (2014) · cites this paper as [1]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Miller, M. R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Crapo, R., Enright, P., van der Grinten, C. P. M., Gustafsson, P., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00034805 · Cited by 15,627
ATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Interpretative strategies for lung function tests
Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R. O., Burgos, F., Casaburi, R., Coates, A., van der Grinten, C. P. M., Gustafsson, P., Hankinson, J., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00035205 · Cited by 5,945
Fleischner Society: Glossary of Terms for Thoracic Imaging
Hansell, D. M., Bankier, A. A., MacMahon, H., McLoud, T. C., Müller, N. L., & Remy, J. (2008) · Radiology · doi:10.1148/radiol.2462070712 · Cited by 4,198
Self-citation(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Standardisation of the measurement of lung volumes
Wanger, J., Clausen, J. L., Coates, A., Pedersen, O. F., Brusasco, V., Burgos, F., Casaburi, R., Crapo, R., Enright, P., van der Grinten, C. P. M., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00035005 · Cited by 2,768
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Standardisation of the single-breath determination of carbon monoxide uptake in the lung
MacIntyre, N., Crapo, R. O., Viegi, G., Johnson, D. C., van der Grinten, C. P. M., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Enright, P., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00034905 · Cited by 2,255
NOCTURNAL OXYGEN THERAPY TRIAL GROUP* (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-3-391 · Cited by 2,218
Research works printed but not linked: 9
- Cochrane Handbook for Systematic Reviews of Interventions 5.0.2. Oxford: The Cochrane Collaboration, 2009. [online] 2009. [accessed 20 June 2010]; Available from: http://www.cochrane.org/resources/handbook/.
- Nadrous HF, Ryu JH, Douglas WW, Decker PA, Olson EJ. Impact of angiotensin-converting enzyme inhibitors and statins on survival in idiopathic pulmonary fibrosis. Chest 2004;126:438–446. [DOI] [PubMed] [Google Scholar]
- 2005, J Gastrointest Surg, 1053
- Marshall RP, Puddicombe A, Cookson WO, Laurent GJ. Adult familial cryptogenic fibrosing alveolitis in the UK. Thorax 2000;55:143–146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med 2001;345:517–525. [DOI] [PubMed] [Google Scholar]
- Kondo A, Saiki S. Acute exacerbation in idiopathic interstitial pneumonia (IIP). In: Harasawa M, Fukuchi Y, Morinari H, editors. Interstitial pneumonia of unknown etiology. Tokyo: University of Tokyo Press; 1989. pp. 33–42.
- Flaherty KR, Colby TV, Toews GB, Travis WD, Flint A, Gay SE, Strawderman RL III, Jain A, Lynch JP III, Martinez FJ. Differential presence of fibroblastic foci in UIP patients with or without conntective tissue disease. Am J Respir Crit Care Med 2001;163:A983. [Google Scholar]
- Molina-Molina M, Badia JR, Marin-Arguedas A, Xaubet A, Santos MJ, Nicolas JM, Ferrer M, Torres A. Outcomes and clinical characteristics of patients with pulmonary fibrosis and respiratory failure admitted to an intensive care unit: a study of 20 cases. Med Clin (Barc) 2003;121:63–67. [DOI] [PubMed] [Google Scholar]
- Pitsiou G, Ioannis Trigonis I, Tsiata E, Kontou P, Manolakoglou N, Stanopoulos I, Mavrofridis E, Argyropoulou P. Outcome of patients with pulmonary fibrosis admitted to the ICU for acute respiratory failure. Eur Respir J Suppl 2006;28:E650. [Google Scholar]
Cited by
Items 901–1,000 of 1,060
Reichmann, W. M., Yu, Y., Macaulay, D. S., Wu, E. Q., & Nathan, S. D. (2015) · BMC Pulmonary Medicine · doi:10.1186/s12890-015-0161-5 · Cited by 85
on behalf of the IPF-PRO™ Registry investigators, Snyder, L., Neely, M. L., Hellkamp, A. S., O’Brien, E., de Andrade, J., Conoscenti, C. S., Leonard, T., Bender, S., Gulati, M., et al. (2019) · Respiratory Research · doi:10.1186/s12931-019-1043-9 · Cited by 85
Gazdhar, A., Susuri, N., Hostettler, K., Gugger, M., Knudsen, L., Roth, M., Ochs, M., & Geiser, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065453 · Cited by 85
Inhalation treatment of idiopathic pulmonary fibrosis with curcumin large porous microparticles
Hu, Y., Li, M., Zhang, M., & Jin, Y. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.09.031 · Cited by 85
Chung, J. H., Zhan, X., Cao, M., Koelsch, T. L., Manjarres, D. C. G., Brown, K. K., Lynch, D. A., Russell, G., & Pérez, E. R. F. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201701-035oc · Cited by 85
Self-citationIsshiki, T., Sakamoto, S., Kinoshita, A., Sugino, K., Kurosaki, A., & Homma, S. A. (2015) · Respiration · doi:10.1159/000369828 · Cited by 85
Izuka, S., Yamashita, H., Iba, A., Takahashi, Y., & Kaneko, H. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa608 · Cited by 85
Gui, X., Shi, S., Ding, H. J., Wang, R., Tong, J., Yu, M., Zhao, T., Ma, M., Ding, J., Xin, X., et al. (2022) · Rheumatology · doi:10.1093/rheumatology/keac090 · Cited by 85
Role of Lung Microbiome in Innate Immune Response Associated With Chronic Lung Diseases
Paudel, K. R., Dharwal, V., Patel, V. K., Galvão, I., Wadhwa, R., Malyla, V., Shen, S., Budden, K. F., Hansbro, N. G., Vaughan, A., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00554 · Cited by 84
Tobacco Smoke–Induced Lung Fibrosis and Emphysema
Morse, D., & Rosas, I. O. (2014) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170411 · Cited by 84
Validation of the GAP Score in Korean Patients With Idiopathic Pulmonary Fibrosis
Kim, E. S., Choi, S. M., Lee, J., Park, Y. S., Lee, C., Yim, J., Yoo, C., Kim, Y. W., Han, S. K., & Lee, S. (2014) · CHEST Journal · doi:10.1378/chest.14-0453 · Cited by 84
Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis
Bahmer, T., Kirsten, A.-M., Waschki, B., Rabe, K. F., Magnussen, H., Kirsten, D., Gramm, M., Hummler, S., Brunnemer, E., Kreuter, M., et al. (2017) · BMC Pulmonary Medicine · doi:10.1186/s12890-017-0444-0 · Cited by 84
Morais, A., Beltrão, M., Sokhatska, O., Costa, D., Melo, N. C. V., Mota, P. C., Marques, A., & Delgado, L. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.06.003 · Cited by 84
Real-World Experience with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis
Brunnemer, E., Wälscher, J., Ehlers-Tenenbaum, S., Hausmanns, J., Schulze, K., Seiter, M., Heußel, C. P., Warth, A., Herth, F. J. F., & Kreuter, M. (2018) · Respiration · doi:10.1159/000485933 · Cited by 84
Pirfenidone for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis
Aravena, C., Gonzalo Labarca, T., Venegas, C., Arenas, Á., & Rada, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136160 · Cited by 84
Let-7d microRNA affects mesenchymal phenotypic properties of lung fibroblasts
Huleihel, L., Ben-Yehudah, A., Milosevic, J., Yu, G., Pandit, K., Sakamoto, K., Yousef, H., LeJeune, M., Coon, T. A., Redinger, C. J., et al. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00149.2013 · Cited by 84
Lee, S. H., Lee, E. J., Lee, S. Y., Kim, J. H., Shim, J. J., Shin, C., In, K. H., Kang, K. H., Uhm, C. S., Kim, H. K., et al. (2014) · Experimental Lung Research · doi:10.3109/01902148.2014.881930 · Cited by 84
Kang, J., Han, M., & Song, J. W. (2020) · Scientific Reports · doi:10.1038/s41598-020-72607-1 · Cited by 84
Yoon, J. H., Nouraie, M. S., Chen, X., Zou, R. H., Sellarés, J., Veraldi, K. L., Chiarchiaro, J., Lindell, K. O., Wilson, D. O., Kaminski, N., et al. (2018) · Respiratory Research · doi:10.1186/s12931-018-0899-4 · Cited by 84
Fujimoto, D., Kato, R., Morimoto, T., Shimizu, R., Sato, Y., Kogo, M., Ito, J., Teraoka, S., Nagata, K., Nakagawa, A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168465 · Cited by 84
Alveolar epithelial disintegrity in pulmonary fibrosis
Kulkarni, T., de Andrade, J. A., Zhou, Y., Luckhardt, T., & Thannickal, V. J. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00115.2016 · Cited by 84
Ogura, T., Azuma, A., Inoue, Y., Taniguchi, H., Chida, K., Bando, M., Niimi, Y., Kakutani, S., Suga, M., Sugiyama, Y., et al. (2015) · Respiratory Investigation · doi:10.1016/j.resinv.2015.06.001 · Cited by 84
Taz, T. A., Ahmed, K., Paul, B. K., Kawsar, M., Aktar, N., Mahmud, S. M. H., & Moni, M. A. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa235 · Cited by 84
Vu, T. N., Chen, X., Foda, H. D., Smaldone, G. C., & Hasaneen, N. A. (2019) · Respiratory Research · doi:10.1186/s12931-019-1171-2 · Cited by 84
Fraser, E., Denney, L., Antanaviciute, A., Blirando, K., Vuppusetty, C., Zheng, Y., Repapi, E., Iotchkova, V., Taylor, S., Ashley, N., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.623430 · Cited by 83
Unclassifiable interstitial lung diseases: Clinical characteristics and survival
Hyldgaard, C., Bendstrup, E. M., Wells, A. U., & Hilberg, O. (2016) · Respirology · doi:10.1111/resp.12931 · Cited by 83
Self-citationDowman, L. M., McDonald, C. F., Bozinovski, S., Vlahos, R., Gillies, R., Pouniotis, D., Hill, C. J., Goh, N. S. L., & Holland, A. E. (2017) · Respirology · doi:10.1111/resp.13002 · Cited by 83
Wells, A. U., Behr, J., Costabel, U., Cottin, V., Poletti, V., Richeldi, L., & for the European IPF consensus group (2012) · Thorax · doi:10.1136/thoraxjnl-2012-202580 · Cited by 83
Self-citationBelkin, A., Albright, K., & Swigris, J. J. (2014) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2013-000007 · Cited by 83
Self-citationEkström, M. P., Gustafson, T., Boman, K., Nilsson, K., Tornling, G., Murgia, N., & Torén, K. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004018 · Cited by 83
The usefulness of monomeric periostin as a biomarker for idiopathic pulmonary fibrosis
Ohta, S., Okamoto, M., Fujimoto, K., Sakamoto, N., Takahashi, K., Yamamoto, H., Kushima, H., Ishii, H., Akasaka, K., Ono, J., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174547 · Cited by 83
Self-citationX-Linked Inhibitor of Apoptosis Regulates Lung Fibroblast Resistance to Fas-Mediated Apoptosis
Ajayi, I. O., Sisson, T. H., Higgins, P., Booth, A. J., Sagana, R. L., Huang, S. K., White, E. S., King, J. E., Moore, B. B., & Horowitz, J. C. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0224oc · Cited by 83
The broad spectrum of lung diseases in primary antibody deficiencies
Cinetto, F., Scarpa, R., Rattazzi, M., & Agostini, C. (2018) · European Respiratory Review · doi:10.1183/16000617.0019-2018 · Cited by 83
Are Transbronchial Cryobiopsies Ready for Prime Time? A Systematic Review and Meta-Analysis
Sethi, J. S., Ali, M. S., Mohananey, D., Nanchal, R. S., Maldonado, F., & Musani, A. I. (2018) · Journal of Bronchology & Interventional Pulmonology · doi:10.1097/lbr.0000000000000519 · Cited by 83
Chen, N., Collum, S. D., Luo, F., Weng, T., Le, T.-T., Hernandez, A. M., Philip, K., Molina, J. G., Garcia‐Morales, L. J., Cao, Y., et al. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00142.2016 · Cited by 83
Lipid nanoparticle-mediated mRNA delivery in lung fibrosis
Massaro, M., Wu, S., Baudo, G., Liu, H., Collum, S. D., Lee, H., Stigliano, C., Segura-Ibarra, V., Karmouty‐Quintana, H., & Blanco, E. (2023) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106370 · Cited by 82
Jiang, C., Huang, H. F., Liu, J., Wang, Y., Lu, Z., & Xu, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047024 · Cited by 82
Comprehensive Supportive Care for Patients with Fibrosing Interstitial Lung Disease
Wijsenbeek, M. S., Holland, A. E., Swigris, J. J., & Renzoni, E. A. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201903-0614pp · Cited by 82
Self-citationRicheldi, L., Scholand, M. B., Lynch, D. A., Colby, T. V., Myers, J. L., Groshong, S. D., Chung, J. H., Benzaquen, S., Nathan, S. D., Davis, J. R., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202003-0877oc · Cited by 82
Self-citationTheMUC5Bpromoter polymorphism is associated with specific interstitial lung abnormality subtypes
Putman, R. K., Guðmundsson, G., Araki, T., Nishino, M., Sigurdsson, S. O., Gudmundsson, E. F., Eiríksdóttir, G., Aspelund, T., Ross, J. C., Estépar, R. S. J., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00537-2017 · Cited by 82
Idiopathic pulmonary fibrosis and GERD: links and risks
Ghisa, M., Marinelli, C., Savarino, V., & Savarino, E. V. (2019) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s184291 · Cited by 82
Inomata, M., Ikushima, S., Awano, N., Kondoh, K., Satake, K., Masuo, M., Kusunoki, Y., Moriya, A., Kamiya, H., Ando, T., et al. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-104 · Cited by 82
The current position of surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis
Kaarteenaho, R. L. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-43 · Cited by 82
Transbronchial cryobiopsy in interstitial lung disease: experience in 106 cases – how to do it
Bango, A., Ariza‐Prota, M., Rivas, H. E. T., Fernández, L., Prieto, A., Sánchez, I., Gil, M., & Pando‐Sandoval, A. (2017) · ERJ Open Research · doi:10.1183/23120541.00148-2016 · Cited by 82
Enomoto, N., Mikamo, M., Oyama, Y., Kono, M., Hashimoto, D., Fujisawa, T., Inui, N., Nakamura, Y., Yasuda, H., Kato, A., et al. (2015) · BMC Pulmonary Medicine · doi:10.1186/s12890-015-0004-4 · Cited by 82
Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis
Tzouvelekis, A., Toonkel, R. L., Karampitsakos, Τ., Medapalli, K., Ninou, I., Aidinis, V., Bouros, D. E., & Glassberg, M. K. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00142 · Cited by 82
Self-citationGenetics of idiopathic pulmonary fibrosis: from mechanistic pathways to personalised medicine
Spagnolo, P., & Cottin, V. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-103973 · Cited by 82
Matson, S. M., Lee, J. S., & Eickelberg, O. (2020) · European Respiratory Journal · doi:10.1183/13993003.02533-2020 · Cited by 82
Phenotype of Normal Spirometry in an Aging Population
Fragoso, C. A. V., McAvay, G., Ness, P. H. V., Casaburi, R. H., Jensen, R. L., MacIntyre, N. R., Gill, T. M., Yaggi, H. K., & Concato, J. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201503-0463oc · Cited by 82
Li, S., Shi, J., & Tang, H. (2021) · Cell Biology and Toxicology · doi:10.1007/s10565-021-09676-z · Cited by 82
Acute exacerbation of IPF following diagnostic bronchoalveolar lavage procedures
Sakamoto, K., Taniguchi, H., Kondoh, Y., Wakai, K., Kimura, T., Kataoka, K., Hashimoto, N., Nishiyama, O., & Hasegawa, Y. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.11.006 · Cited by 82
Self-citationKono, M., Nakamura, Y., Enomoto, N., Hashimoto, D., Fujisawa, T., Inui, N., Maekawa, M., Suda, T., Colby, T. V., & Chida, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094775 · Cited by 82
Self-citationGolchin, N., Patel, A., Scheuring, J., Wan, V., Hofer, K., Collet, J., Elpers, B., & Lesperance, T. (2025) · BMC Pulmonary Medicine · doi:10.1186/s12890-025-03836-1 · Cited by 81
Wang, K., Ju, Q., Cao, J., Tang, W., & Zhang, J. (2017) · Medicine · doi:10.1097/md.0000000000007083 · Cited by 81
Bargagli, E., Piccioli, C., Rosi, E., Torricelli, E., Turi, L., Piccioli, E., Pistolesi, M., Ferrari, K., & Voltolini, L. (2019) · Pulmonology · doi:10.1016/j.pulmoe.2018.06.003 · Cited by 81
Integrating pathology and radiology disciplines: an emerging opportunity?
Sorace, J., Aberle, D. R., Elimam, D., Lawvere, S., Tawfik, O., & Wallace, W. D. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-100 · Cited by 81
Wang, C., Song, X., Li, Y., Han, F., Gao, S., Wang, X., Xie, S., & Lv, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070725 · Cited by 81
Fujimoto, D., Morimoto, T., Ito, J., Sato, Y., Ito, M., Teraoka, S., Otsuka, K., Nagata, K., Nakagawa, A., & Tomii, K. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.06.008 · Cited by 81
Tonelli, R., Cocconcelli, E., Lanini, B., Romagnoli, P., Florini, F., Castaniere, I., Andrisani, D., Cerri, S., Luppi, F., Fantini, R., et al. (2017) · BMC Pulmonary Medicine · doi:10.1186/s12890-017-0476-5 · Cited by 81
Margaritopoulos, G., Vasarmidi, E., & Antoniou, K. (2016) · Core Evidence · doi:10.2147/ce.s76549 · Cited by 81
Burden of Idiopathic Pulmonary Fibrosis Progression: A 5-Year Longitudinal Follow-Up Study
Cottin, V., Schmidt, A., Laura, C., Fanny, P., Céline, F.-M., Lay, K. L., & Bénard, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0166462 · Cited by 81
Hetzel, J., Wells, A. U., Costabel, U., Colby, T. V., Walsh, S. L. F., Verschakelen, J., Cavazza, A., Tomassetti, S., Ravaglia, C., Böckeler, M., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.01520-2019 · Cited by 81
Self-citationIwata, T., Yoshida, S., Nagato, K., Nakajima, T., Suzuki, H., Tagawa, T., Mizobuchi, T., Ota, S., Nakatani, Y., & Yoshino, I. (2014) · Surgery Today · doi:10.1007/s00595-014-1071-5 · Cited by 81
Kameda, M., Otsuka, M., Chiba, H., Kuronuma, K., Hasegawa, T., Takahashi, H., & Takahashi, H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241719 · Cited by 81
Combined pulmonary fibrosis and emphysema in connective tissue disease
Cottin, V., & Cordier, J.-F. (2012) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328356803b · Cited by 81
Self-citationGlick, D., Lyen, S. M., Kandel, S., Shapera, S., Le, L. W., Lindsay, P. E., Wong, O., Bezjak, A., Brade, A. M., Cho, J., et al. (2017) · Clinical Lung Cancer · doi:10.1016/j.cllc.2017.06.021 · Cited by 81
Diagnostic delay of associated interstitial lung disease increases mortality in rheumatoid arthritis
Cano-Jiménez, E., Rodríguez, T. R. V., Martín-Robles, I., Castillo, D., García, J. J., de Miguel, E. B., Robles-Pérez, A., Galván, M. F., Roibas, C. M., Lara, S. H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-88734-2 · Cited by 81
Molecular breath analysis supports altered amino acid metabolism in idiopathic pulmonary fibrosis
Gaugg, M. T., Engler, A., Bregy, L., Nussbaumer‐Ochsner, Y., Eiffert, L., Bruderer, T., Zenobi, R., Sinues, P., & Kohler, M. (2019) · Respirology · doi:10.1111/resp.13465 · Cited by 81
Weight loss as a predictor of mortality in patients with interstitial lung disease
Pugashetti, J. V., Graham, J., Boctor, N., Méndez, C., Foster, E. E., Juarez, M. M., Harper, R. W., Morrissey, B., Kadoch, M. A., & Oldham, J. M. (2018) · European Respiratory Journal · doi:10.1183/13993003.01289-2018 · Cited by 81
Shioya, M., Otsuka, M., Yamada, G., Umeda, Y., Ikeda, K., Nishikiori, H., Kuronuma, K., Chiba, H., & Takahashi, H. (2018) · Canadian Respiratory Journal · doi:10.1155/2018/6043053 · Cited by 81
Utilización de criosondas para la realización de la biopsia pulmonar transbronquial
Pajares, V., Torregó, A., Puzo, C., Lerma, E., de Bernabé, M. A. G., & Franquet, T. (2009) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2009.09.012 · Cited by 81
Pleural mesothelial cells in pleural and lung diseases.
Batra, H., & Antony, V. B. (2015) · PubMed · doi:10.3978/j.issn.2072-1439.2015.02.19 · Cited by 80
Coghlan, M. A., Shifren, A., Huang, H. J., Russell, T. D., Mitra, R. D., Zhang, Q., Wegner, D. J., Cole, F. S., & Hamvas, A. (2014) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2014-000057 · Cited by 80
Abramson, M. J., Murambadoro, T., Alif, S. M., Benke, G. P., Dharmage, S. C., Glaspole, I., Hopkins, P., Hoy, R. F., Klebe, S., Moodley, Y., et al. (2020) · Thorax · doi:10.1136/thoraxjnl-2019-214478 · Cited by 80
Role of MicroRNAs in Lung Disease
Angulo, M., Lecuona, E., & Sznajder, J. I. (2012) · Archivos de Bronconeumología (English Edition) · doi:10.1016/j.arbr.2012.06.015 · Cited by 80
Torrisi, S. E., Ley, B., Kreuter, M., Wijsenbeek, M., Vittinghoff, E., Collard, H. R., & Vancheri, C. (2019) · European Respiratory Journal · doi:10.1183/13993003.01587-2018 · Cited by 79
Self-citationPhase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis
Maher, T. M., Costabel, U., Glassberg, M. K., Kondoh, Y., Ogura, T., Scholand, M. B., Kardatzke, D., Howard, M., Olsson, J., Neighbors, M., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.02442-2019 · Cited by 79
Self-citationNathan, S. D., Costabel, U., Albera, C., Behr, J., Wuyts, W. A., Kirchgaessler, K.-U., Stauffer, J. L., Morgenthien, E., Chou, W., Limb, S. L., et al. (2019) · Respiratory Medicine · doi:10.1016/j.rmed.2019.04.016 · Cited by 79
Self-citationEfficacy of pirfenidone for idiopathic pulmonary fibrosis: An Italian real life study
Harari, S., Caminati, A., Albera, C., Vancheri, C., Poletti, V., Pesci, A., Luppi, F., Saltini, C., Agostini, C., Bargagli, E., et al. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.04.010 · Cited by 78
Epidemiology of Idiopathic Pulmonary Fibrosis in Northern Italy
Harari, S., Madotto, F., Caminati, A., Conti, S., & Cesana, G. (2016) · PLOS ONE · doi:10.1371/journal.pone.0147072 · Cited by 78
S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis
Hara, A., Sakamoto, N., Ishimatsu, Y., Kakugawa, T., Nakashima, S., Hara, S., Adachi, M., Fujita, H., Mukae, H., & Kohno, S. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2011.12.010 · Cited by 78
Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosis
Yoon, H.-Y., Park, S., Kim, D. S., & Song, J. W. (2018) · Respiratory Research · doi:10.1186/s12931-018-0907-8 · Cited by 78
Self-citationWim, A., Stijn, W., Stijn, E., Bart, M., Marijke, W., Christophe, D., Jonas, Y., Jana, S., Eric, K., & Geert, M. (2013) · Annals of Thoracic Medicine · doi:10.4103/1817-1737.105718 · Cited by 78
Mortality Risk Prediction in Scleroderma-Related Interstitial Lung Disease
Morisset, J., Vittinghoff, E., Elicker, B. M., Hu, X., Le, S., Ryu, J. H., Jones, K. D., Haemel, A., Golden, J. A., Boin, F., et al. (2017) · Chest · doi:10.1016/j.chest.2017.06.009 · Cited by 77
Self-citationJo, H. E., Glaspole, I., Moodley, Y., Chapman, S., Ellis, S., Goh, N., Hopkins, P., Keir, G., Mahar, A., Cooper, W., et al. (2018) · BMC Pulmonary Medicine · doi:10.1186/s12890-018-0575-y · Cited by 77
Pulmonary fibrosis in the era of stratified medicine
Mathai, S. K., Newton, C. A., Schwartz, D. A., & Garcia, C. K. (2016) · Thorax · doi:10.1136/thoraxjnl-2016-209172 · Cited by 77
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression
Jones, D. L., Haak, A. J., Caporarello, N., Choi, K. M., Ye, Z., Yan, H., Varelas, X., Ordog, T., Ligresti, G., & Tschumperlin, D. J. (2019) · Journal of Cell Science · doi:10.1242/jcs.233486 · Cited by 77
OSA and Prolonged Oxygen Desaturation During Sleep are Strong Predictors of Poor Outcome in IPF
Bosi, M., Milioli, G., Fanfulla, F., Tomassetti, S., Ryu, J. H., Parrino, L., Riccardi, S., Melpignano, A., Vaudano, A. E., Ravaglia, C., et al. (2017) · Lung · doi:10.1007/s00408-017-0031-4 · Cited by 77
Self-citation“Velcro-type” crackles predict specific radiologic features of fibrotic interstitial lung disease
Sgalla, G., Walsh, S. L. F., Sverzellati, N., Fletcher, S., Cerri, S., Dimitrov, B., Nikolic, D., Barney, A., Pancaldi, F., Larcher, L., et al. (2018) · BMC Pulmonary Medicine · doi:10.1186/s12890-018-0670-0 · Cited by 76
Self-citationCerri, S., Monari, M., Guerrieri, A., Donatelli, P., Bassi, I., Garuti, M., Luppi, F., Betti, S., Bandelli, G., Carpano, M., et al. (2019) · Respiratory Medicine · doi:10.1016/j.rmed.2019.105803 · Cited by 76
Molecular Biomarkers in Idiopathic Pulmonary Fibrosis: State of the Art and Future Directions
Stainer, A., Faverio, P., Busnelli, S., Catalano, M., Della Zoppa, M., Marruchella, A., Pesci, A., & Luppi, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126255 · Cited by 76
Boddupalli, A., Zhu, L., & Bratlie, K. M. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600532 · Cited by 76
O'Brien, E. C., Durheim, M. T., Gamerman, V., Garfinkel, S., Anstrom, K. J., Palmer, S. M., & Conoscenti, C. S. (2016) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2015-000108 · Cited by 75
VCAM-1 is a TGF-β1 inducible gene upregulated in idiopathic pulmonary fibrosis
Agassandian, M., Tedrow, J. R., Sembrat, J., Kass, D. J., Zhang, Y., Goncharova, E. A., Kaminski, N., Mallampalli, R. K., & Vuga, L. J. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.09.003 · Cited by 75
Quantitative proteomic characterization of lung tissue in idiopathic pulmonary fibrosis
Tian, Y., Li, H., Gao, Y., Liu, C., Qiu, T., Wu, H., Cao, M., Zhang, Y., Ding, H., Chen, J., et al. (2019) · Clinical Proteomics · doi:10.1186/s12014-019-9226-4 · Cited by 74
T cells in idiopathic pulmonary fibrosis: crucial but controversial
Deng, L., Huang, T., & Zhang, L. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01344-x · Cited by 74
Persistent Lung Inflammation and Fibrosis in Serum Amyloid P Component (Apcs-/-) Knockout Mice
Pilling, D., & Gomer, R. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093730 · Cited by 74
Nintedanib in the treatment of idiopathic pulmonary fibrosis
Mazzei, M. E., Richeldi, L., & Collard, H. R. (2015) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465815579365 · Cited by 74
Self-citationEffect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis
Kärkkäinen, M., Kettunen, H.-P., Nurmi, H., Selander, T., Purokivi, M., & Kaarteenaho, R. (2017) · Respiratory Research · doi:10.1186/s12931-017-0642-6 · Cited by 72
Proteomic Biomarkers of Survival in Idiopathic Pulmonary Fibrosis
Oldham, J. M., Huang, Y., Bose, S., Ma, S.-F., Kim, J. S., Schwab, A., Ting, C., Mou, K., Lee, C. T., Adegunsoye, A., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202301-0117oc · Cited by 72
Self-citation
Metadata
- Authors
- Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., Lynch, D. A., Ryu, J. H., Swigris, J. J., Wells, A. U., Ancochea, J., Bouros, D., Carvalho, C., Costabel, U., Ebina, M., Hansell, D. M., Johkoh, T., Kim, D. S., King, T. E., Kondoh, Y., Myers, J., Müller, N. L., Nicholson, A. G., Richeldi, L., Selman, M., Dudden, R. F., Griss, B. S., Protzko, S. L., & Schünemann, H. J.
- Affiliations
- University of Washington (US)
- University of California, San Francisco (US)
- Mater Misericordiae University Hospital (IE)
- Ludwig-Maximilians-Universität München (DE)
- Mayo Clinic (US)
- University of Michigan (US)
- Tulane University (US)
- University of Colorado Boulder (US)
- National Jewish Health (US)
- Royal Brompton Hospital (GB)
- Hospital Universitario de La Princesa (ES)
- University Hospital of Alexandroupolis (GR)
- Universidade de São Paulo (BR)
- Tohoku University (JP)
- Royal Brompton & Harefield NHS Foundation Trust (GB)
- The University of Osaka (JP)
- University of Ulsan (KR)
- University of Modena and Reggio Emilia (IT)
- Instituto Nacional de Enfermedades Respiratorias (MX)
- ORCID
- Raghu, Ganesh
- Collard, Harold R.
- Colby, Thomas V.
- Lasky, Joseph A.
- Lynch, David A.
- Ryu, Jay H.
- Swigris, Jeffrey J.
- Wells, Athol U.
- Ancochea, Julio
- Bouros, Demosthenes
- Carvalho, Carlos
- Costabel, Ulrich
- Johkoh, Takeshi
- King, Talmadge E.
- Kondoh, Yasuhiro
- Myers, Jeffrey
- Nicholson, Andrew G.
- Richeldi, Luca
- Selman, Moisés
- Schünemann, Holger J.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03
- Volume
- 183
- Issue
- 6
- Pages
- 788-824
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- PMC
- PMC5450933
- OpenAlex
- W2167383172
- Cited by
- 7,186
- References
- 325
- Citations by year
- 2026: 187 · 2025: 307 · 2024: 436 · 2023: 432 · 2022: 522 · 2021: 640 · 2020: 607 · 2019: 596 · 2018: 607 · 2017: 605 · 2016: 569 · 2015: 531 · 2014: 426 · 2013: 370 · 2012: 256
- FWCI
- 304.18
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Funders
- National Heart, Lung, and Blood Institute (K23HL092227)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- idiopathic pulmonary fibrosis, diagnosis, management, natural history (disease), staging, prognosis, risk factors, treatment, disease surveillance, GRADE
- MeSH terms
- Europe, Humans, International Cooperation, Japan, Latin America, Societies, Medical, United States, Evidence-Based Medicine, Idiopathic Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.